Long term outcome after single and bilateral lung transplantation for end-stage pulmonary hypertension

2004 ◽  
Vol 23 (2) ◽  
pp. S94
Author(s):  
M de Perrot ◽  
Y Shargall ◽  
T.K Waddell ◽  
J Granton ◽  
K McRae ◽  
...  
BMC Surgery ◽  
2015 ◽  
Vol 15 (1) ◽  
Author(s):  
Shun-Mao Yang ◽  
Shu-Chien Huang ◽  
Shuenn-Wen Kuo ◽  
Pei-Ming Huang ◽  
Sung-Ching Pan ◽  
...  

2021 ◽  
Vol 30 (3) ◽  
pp. 178-183
Author(s):  
Kate McEwen ◽  
Lyndell Brodie

Lung transplantation is a well-established treatment for a variety of end-stage pulmonary diseases. However, the journey of a lung transplant recipient is complex and multifaceted. Silicosis is a rare indication for lung transplantation, but no other treatment is yet available for this disease in its end stages. This Australian case study presents a 52-year-old man with silicosis who received bilateral lung transplantation. The patient was frequently noncompliant with noninvasive ventilation therapy and experienced the complication of type 2 respiratory failure. Patient education and support provided, particularly around medication management following transplantation surgery, are discussed here. The patient's social situation and its implications for both him and his family are also considered.


Sign in / Sign up

Export Citation Format

Share Document